Physician profile
Meredith A Perrin
NPI 1083978027
$3,606.93
in general payments reported to CMS, 2019-2025
23 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,377 · 2020: $96.90 · 2021: $362 · 2022: $585 · 2023: $680 · 2024: $83.42 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $664.46 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $408.96 | 2019-2024 | Zepbound, Taltz, Olumiant |
| Genzyme Corporation | $361.45 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $324.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $288.60 | 2019-2025 | |
| Amgen INC. | $275.51 | 2019-2025 | Otezla |
| Abbvie INC. | $219.75 | 2019-2025 | |
| Celgene Corporation | $182.49 | 2019 | |
| Leo Pharma INC. | $164.92 | 2019-2025 | Anzupgo, Adbry |
| Incyte Corporation | $132.51 | 2022-2025 | Opzelura |
| Glaxosmithkline, LLC. | $113.44 | 2021 | |
| Sun Pharmaceutical Industries INC. | $100.32 | 2021-2025 | Ilumya |
| Epi Health, LLC | $78.33 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $49.31 | 2019-2025 | Dupixent |
| Pfizer INC. | $46.32 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $43.69 | 2019-2021 | |
| Organon LLC | $27.59 | 2025 | |
| Almirall LLC | $24.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.23 | 2022 | |
| Mylan Pharmaceuticals INC. | $22.42 | 2019 | |
| Genentech USA, INC. | $21.06 | 2019 | |
| Tanabe Pharma America, INC. | $17.81 | 2019 | |
| Prugen, INC. Pharmaceuticals | $16.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Perrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.